SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0000812796-07-000070
Filing Date
2007-08-15
Accepted
2007-08-14 19:30:44
Documents
6
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 10 QSB FOR 2Q 2007 dor10q2q2007.htm 10QSB 445490
2 CEO CERT 2Q 2007 ceocert2q2007.htm EX-31.1 9716
3 CFO CERT 2Q 2007 cfocert2q2007.htm EX-31.2 9724
4 CEO 906 SOX 2Q 2007 ceo9062q2007.htm EX-32.1 5043
5 CFO 906 SOX 2Q 2007 cfo9062q2007.htm EX-32.2 4906
6 RISK FACTORS 2Q 2007 riskfactors022007.htm EX-99.1 71470
  Complete submission text file 0000812796-07-000070.txt   547966
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 071057673
SIC: 2834 Pharmaceutical Preparations